Jesse Seton McGreivy
Amministratore Delegato presso Kartos Therapeutics, Inc.
Profilo
Jesse Seton McGreivy is currently the Chief Executive Officer & Chief Marketing Officer at Kartos Therapeutics, Inc. Prior to this, he worked as a Medical Director-Clinical Research at Amgen, Inc. from 2006 to 2012, and as a Vice President-Clinical Science at Pharmacyclics LLC from 2012 to 2013.
He also worked as a Clinical Scientist at Hoffmann-La Roche, Inc. Dr. McGreivy holds a doctorate degree from The Ohio State University and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Jesse Seton McGreivy
| Società | Posizione | Inizio |
|---|---|---|
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Amministratore Delegato | - |
Precedenti posizioni note di Jesse Seton McGreivy
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2012 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| PHARMACYCLICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jesse Seton McGreivy
| The Ohio State University | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
- Borsa valori
- Insiders
- Jesse Seton McGreivy
